Consequences of rpoB mutations missed by the GenoType MTBDR plus assay in a programmatic setting in South Africa.
Nomonde Ritta MvelaseLindiwe P CeleRavesh SinghYeshnee NaidooJennifer GiandhariEduan WilkinsonTulio de OliveiraKhine Swe Swe-HanKoleka P MlisanaPublished in: African journal of laboratory medicine (2023)
. This led to substantial delays in the initiation of appropriate therapy. The previous tuberculosis treatment history and the high level of resistance to other anti-tuberculosis drugs suggest an accumulation of resistance.